Publications by authors named "Olivia A Wheaton"
Article Synopsis
- - The study examined the long-term effects of testosterone replacement therapy (TRT) on quality of life (QOL) and sexual function in men with low testosterone levels, using data from a multinational registry over 36 months.
- - Results showed that men receiving TRT experienced significant improvements in QOL and sexual function, reporting fewer symptoms compared to those who did not receive treatment; TRT patients scored better on established assessment scales like the AMS and IIEF.
- - The findings suggest that TRT can lead to sustained enhancements in the life quality of men with hypogonadism, although some improvement was also noted in untreated patients, emphasizing the effectiveness of TRT over time.
Aims: The aim of this study was to assess cardiovascular (CV) safety of testosterone replacement therapy (TRT) in a large, diverse cohort of European men with hypogonadism (HG).
Methods: The Registry of Hypogonadism in Men (RHYME) was designed as a multi-national, longitudinal disease registry of men diagnosed with hypogonadism (HG) at 25 clinical sites in six European countries. Data collection included a complete medical history, physical examination, blood sampling and patient questionnaires at multiple study visits over 2-3 years.
Objectives: To evaluate the effects of testosterone-replacement therapy (TRT) on prostate health indicators in hypogonadal men, including rates of prostate cancer diagnoses, changes in prostate-specific antigen (PSA) levels and lower urinary tract symptoms (LUTS) over time.
Patients And Methods: The Registry of Hypogonadism in Men (RHYME) is a multi-national patient registry of treated and untreated, newly-diagnosed hypogonadal men (n = 999). Follow-up assessments were performed at 3-6, 12, 24, and 36 months.